Touchstone International Medical Science Co Ltd

Tianchen Medical disclosed its 2026 semi-annual report on August 27. In the first half, total operating revenue reached 113 million yuan, down 27.43% year on year. Net profit attributable to the parent company was 13.7406 million yuan, down 71.50%. Non-GAAP net profit was 5.073 million yuan, down 88.54%. Net cash flow from operating activities was 6.8326 million yuan, down 81.52%. Basic earnings per share were 0.17 yuan, and the weighted average return on equity was 2.41%, down 6.05 percentage points year on year. The company's core business focuses on surgical staplers and surgical support products. Active products include minimally invasive endoscopic and surgical robot categories, while passive products cover minimally invasive endoscopic and open surgery categories. As of the end of the first half, cash and cash equivalents had decreased by 53.84% from the end of the previous year, short-term borrowings had increased by 178.75%, and long-term borrowings had increased by 127.02%.

Tianchen Medical released its 2026 interim report. First-half net profit attributable to the parent was 13.74 million yuan, down 71.5% year on year. Operating revenue was 113 million yuan, down 27.4% year on year. Net profit attributable to the parent after deducting non-recurring items was 5.07 million yuan, down 88.5% year on year. Net operating cash flow was 6.83 million yuan, down 81.5% year on year. Earnings per share were 0.17 yuan. In the second quarter, operating revenue was 57.66 million yuan, down 36.2% year on year, and net profit attributable to the parent was 4.05 million yuan, down 88.4% year on year. As of the end of the second quarter, total assets were 664 million yuan, down 1.3% from the end of the previous year, and net assets attributable to the parent were 495 million yuan, down 12.5% from the end of the previous year. The company said its main business has not undergone major changes. Its core business continues to focus on surgical staplers and surgical support products, while increasing research and development efforts and advancing projects such as an integrated intelligent surgical platform.